Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï¿¡¼­ Phospholipase C¥ã-1, Epidermal Growth Factor Receptor ¹× Her-2/neu ¹ßÇö ¾ç»ó¿¡ °üÇÑ ¿¬±¸ Value of Phospholipase C¥ã-1, Epidermal Growth Factor Receptor, and Her-2/neu in Human Breast Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 5È£ p.724 ~ 737
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤±âÈÆ/Ki Hoon Jung ¹è¼ºÇÑ/ÀÌÀº¼÷/¹èÁ¤¿ø/±¸¹üȯ/±èÀμ±/ȲÁ¤¿õ/Sung Han Bae/Eun Sook Lee/Jeoung Won Bae/Bum Whan Koo/In Sun Kim/Cheung Wung Whang

Abstract

°á·Ð
°á·ÐÀûÀ¸·Î ¸é¿ªÁ¶Á÷È­Çп°»ö¹ýÀ» ÀÌ¿ëÇÑ PLC¥ã-1, EGFR¹× Her-2/neu´Ü¹é ¹ßÇö ¿©ºÎÀÇ
°üÂûÀº Àüü »ýÁ¸À² ¹× ºñÀç¹ß ´©Àû »ýÁ¸À²°ú PLC¥ã-1, EGFR ¹× Her-2/neu ´Ü¹é ¹ßÇö°ú
À¯ÀÇÇÑ Â÷À̸¦ º¸¿© À¯¹æ¾Ï ¼ö¼ú ÈÄ ¿¹ÈÄ ¿¹Ãø¿¡ À¯¿ëÇÏ°Ô ÀÌ¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÇ
¸ç, À̵éÀº °¢°¢ÀÌ µ¶¸³ÀûÀÎ ¿¹ÈÄ ÀÎÀڷμ­ »Ó¸¸ ¾Æ´Ï¶ó ¼­·Î º´ÇÕÇÏ¿© »ç¿ëÇϸé ÁÁÀº ¿¹ÈÄ
ÀÎÀÚ°¡ µÉ °ÍÀ¸·Î »ý°¢µÈ´Ù.
#ÃÊ·Ï#
Purpose : Oncogen or growth factor receptor such as phospholipase C isoenzyme ¥ã-1
(PLC ¥ã-1), epidermal growth factor receptor (EGFR), and Her-2/neu which related with
tyrosin kinasemay and then regulating yell proliferation may have a role as prognostic
factors for breast cancer.
Material and Methods : With assumption that expression of PLC ¥ã-1, EGFR and
Her-2/neu oncogene has close relationship with prognosis of breast cancer, 59 breast
cancer patients who were operated upon at Korea University Hospital during a period of
6 years starting June 1988 to May 1994 were selected for this study. This study was
carried out by comparing between expression of PLC ¥ã-1, EGFR and Her-2/neu
oncogene and patient's survival rate. These expression were also compared with TNM
system, estrogen and progesterone receptor and at same time these expressions were
compared with each other to see whether there are any relationship among these
expression.
Results : Expression of PLC ¥ã-1, EGFR and Her-2/neu were present in 42% (25/59),
46% (27/59) and 20%(12/59). The expression of PLC ¥ã-1 was closely related with the
expression of EGFR(p<0.05) and Her-2/neu (p<0.05), but there were no relationship
between the expression of PLC ¥ã-1 and hormonal receptors and TNM stage(p>0.05).
The expression of EGFR was closely related with the expression of Her-2/neu(p<0.05)
and hormone receptors(p<0.05), but there were no relationship between the expression of
EGFR and pathologic TNM stage(p>0.05). The expression of Her-2/neu was not closely
related with hormone receptors and TNM stage except axillary lymph node metastasis.
There were close relationship between overall and disease free survival and PLC ¥ã-1
and Her-2/neu. But EGFR had only related with disease free survival rate.
Conclusion : In conclusion, the expression of PLC ¥ã-1, EGFR and Her-2/neu
oncogene in human breast cancer may be useful prognostic factors independently and it
may potentiated its individual value as a prognostic factors if use them together.

Å°¿öµå

Breast cancer; PLC ¥ã-1; Her-2/neu and EGFR;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS